Indeed, Kaufman et al. [68] reported that AKR-001, an Fc-FGF21 analogue, exerts a sustained pharmacodynamic effect on insulin sensitivity and lipid metabolism in patients with T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.